This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2007-2010.
Location History:
- Wallingford, PA (US) (2008)
- Wilmington, DE (US) (2007 - 2010)
Company Filing History:
Years Active: 2007-2010
Title: Bruce Thomas Dembofsky: Innovator in Neurological Treatments
Introduction
Bruce Thomas Dembofsky is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a total of 4 patents to his name, Dembofsky's work focuses on innovative compounds that address critical health issues.
Latest Patents
Dembofsky's latest patents include groundbreaking inventions related to lactams and their uses. One of his notable patents describes compounds that inhibit γ-secretase, which plays a crucial role in the production of amyloid β protein. This innovation aims to prevent the formation of neurological deposits associated with disorders such as Alzheimer's disease. Another patent details novel compounds that provide treatment or prophylaxis for anxiety disorders, cognitive disorders, and mood disorders. These compounds are designed to improve the quality of life for individuals suffering from these conditions.
Career Highlights
Throughout his career, Dembofsky has been associated with AstraZeneca AB, where he has contributed to the development of pharmaceutical solutions. His expertise in the field has led to advancements that have the potential to change the landscape of neurological treatment.
Collaborations
Dembofsky has worked alongside talented colleagues, including Cyrus Ohnmacht and Christopher Becker. Their collaborative efforts have further enhanced the research and development of innovative treatments in the pharmaceutical industry.
Conclusion
Bruce Thomas Dembofsky stands out as a key figure in the realm of pharmaceutical innovation, particularly in addressing neurological disorders. His contributions through patents and collaborations reflect a commitment to improving health outcomes for patients.